EastWest Bioscience Probability of Future Stock Price Finishing Over 0.0

EastWest Bioscience's future price is the expected price of EastWest Bioscience instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of EastWest Bioscience performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
  
Please specify EastWest Bioscience's target price for which you would like EastWest Bioscience odds to be computed.

EastWest Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of EastWest Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for EastWest Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
EastWest Bioscience is not yet fully synchronised with the market data
EastWest Bioscience has some characteristics of a very speculative penny stock
EastWest Bioscience has a very high chance of going through financial distress in the upcoming years
EastWest Bioscience has accumulated 368.4 K in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. EastWest Bioscience has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about EastWest Bioscience's use of debt, we should always consider it together with its cash and equity.
The entity reported the revenue of 626.56 K. Net Loss for the year was (1.61 M) with profit before overhead, payroll, taxes, and interest of 527.6 K.
EastWest Bioscience has accumulated about 19.97 K in cash with (688.47 K) of positive cash flow from operations.
Roughly 31.0% of EastWest Bioscience shares are held by company insiders

EastWest Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of EastWest Stock often depends not only on the future outlook of the current and potential EastWest Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EastWest Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.

EastWest Bioscience Technical Analysis

EastWest Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. EastWest Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of EastWest Bioscience. In general, you should focus on analyzing EastWest Stock price patterns and their correlations with different microeconomic environments and drivers.

EastWest Bioscience Predictive Forecast Models

EastWest Bioscience's time-series forecasting models is one of many EastWest Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary EastWest Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about EastWest Bioscience

Checking the ongoing alerts about EastWest Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for EastWest Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
EastWest Bioscience is not yet fully synchronised with the market data
EastWest Bioscience has some characteristics of a very speculative penny stock
EastWest Bioscience has a very high chance of going through financial distress in the upcoming years
EastWest Bioscience has accumulated 368.4 K in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. EastWest Bioscience has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about EastWest Bioscience's use of debt, we should always consider it together with its cash and equity.
The entity reported the revenue of 626.56 K. Net Loss for the year was (1.61 M) with profit before overhead, payroll, taxes, and interest of 527.6 K.
EastWest Bioscience has accumulated about 19.97 K in cash with (688.47 K) of positive cash flow from operations.
Roughly 31.0% of EastWest Bioscience shares are held by company insiders
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in EastWest Stock

If you are still planning to invest in EastWest Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EastWest Bioscience's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets